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ABSTRACT 
The value of HL-A antigens as genetic markers and epidemiologic tools in various disease 
states is becoming increasingly apparent. The antigens of the HL-A system tthe major histo-
compatibility locus in man) are found on most human cells, especially the leukocytes and 
cells of the epidermis and the dermis. Associations have recently been found for HL-A anti-
gens in psoriasis, atopir dermatitis, systemic lupus erythematosu!i. dermatitis herpetiformis. 
pemphigus vulgaris, and malignant melanoma of the skin; in several other diseases. associa-
tions with HL-A antigens are also probably present. Two possible mechanis ms of association 
of HL-A with various diseases are ( 1) a close linkage between a gene governing immunologic 
responsiveness to a disease and HL-A genes, or (2) antigenic (chemicall cross-reaction be-
tween HL-A antigens and the etiologic agent (e.g., streptocOCCI or viral capsular antigen) 
associated with the disease. 
HL-A is an abbreviation for human leukocyte 
locus A. Since the first leukocyte ant igen "Mac" 
{now called HL-A2) was discovered by Oausset Ill 
in 1958, many poss ible associations of HL-A with 
disease susceptibility have been investigated. The 
most convincing associat ions are with those dis-
eases having a strongly identi fiabl e genetic compo-
nent or involving the skin. HL-A antigens are 
found on most human cells, especially tbe leuko-
cytes and cells of the epidermis and dermis as 
demonstrated by immunoadherence tests [2, :1 ]. 
Although the exact relationships of the HL-A 
specificities to I hese diseases are unknown, in this 
paper I will review some of the experimental and 
epidemiologic work currently in progress with par· 
ticular reference to dermatologically related condi-
tions. 
GENETICS Ot' HL·A 
It is possible to classify a given individual by his 
HL-A type as well as his ABO and red cell types. 
Although the classi fication schemes vary, the types 
noted in Table I have been accorded international 
standardization by a World Health Organization 
agreement [4] . 
Only one chromosome controls a given tissue 
type. From one parent the embryo receives two 
HL-A tissue specificities, one from each locus, 
which are closely linked on a single chromosome. 
This chromosome from one parent matches with its 
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homologue from the other parent. bearing two 
independent specitici t ie::. simi larly linked. The mu-
tually exclusive specificit ies are a llelic. Any given 
individual hru; two chromosomes, one inherited 
from the father and the other from the mother, 
which determine the HL-A type (Fig. I). All 
antigens appear to be codom inant. One each of the 
pairs from the father and mother is inherited by 
the children so that only fou r types ot HL·A 
components are possible from any given mating. 
Between either parent and chil d there is ulwuys 
one haplotype in common; a haplotype consists of 
two markers, one an tigen from each of the segre-
gant series [4] (rig. ll. 
The frequency of some ant igens differs markedly 
among Caucasians and 'egroes. a lthough no anti-
gens are exclusiYe to a given race. Among Orien-
tals. HL-A9 is the most lrcquent. and some anti -
gens, such as HL-Al, :1, and 8, are virtually absent. 
Other antigens. such as W1 7 which is absent in 
Orient als. a re present in a q uarter of the egro 
population [5]. 
Several studies by Takasugi et a l [6] have noted 
that HL-Al is low and HL-A9 is high among 
Jewish persons. a d istribution that IS the direct 
opposite of that found in patients wnh carcinuma 
of the cervix. The low incidence of cervical ('Brei-
noma in ,Jewish women might possibly be related 
to this association. In a recent stud) of p!.oriasis 
171, it was necessary to separate J ews from other 
Caucasians as differences 111 the HL-A frequency 
among the J ewish population were found. Simi-
larly. subgrouping by ethntc group was imaluable 
in the study of pemphigus [81 described belm\. 
Thus it becomes necessar) to control for racial and 
ethnic composition in any analysis of disease states 
for HL-A frequency . 
It should be noted that each specificity b not 
present together with anot her s pecificity of the 
other series in a random manner, but rather in an 
uneven distribution. Thus HL-Al is very Ire-
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TABLE l 
The HL-A system (197,1) 
HL-Al 
HL-A2 
HL-A3 
Locus l 
HL-AS 
HL-AS-AJ 
HL-Ai 
HL-AS 
HL-Al2 
HL-AL:l 
HL-Al4 (Te54l 
HL-Ali (Teiiil 
Locus:! 
TeSS (WL5). [LNO-AJ ; L:-.:0] 
TeSS (\VIS, Cl.'vJl 
Te60 (W!Ol. [BB-SA532; BB; ,JA I 
Te61 (W2l, DA24. E'I') 
Te64 (WIG, Ul8) 
SL-ET 
SLCM 
SL 
HL-A9, l (W2:1J 
HL-A9. 2 (W24) 
HL-AlO, 1 !W2ii) 
HL-A!O, 2 (W26) 
HL-All ULNJ 
HL-A28 (Te40, Bal 
Te6:l (W29, 19, 1) 
Te66 (W31, 19, 4) 
Te59 (W32, 19. 5) 
HL-A27 (Te52J (FJH-A.J; FJHJ 
Te50(W5, RJ 
107 
TT 
Te51 (W22), [AA-AJ; AA I 
14 + Blank gene 
INHERITANCE OF HL-A ANTIGENS 
Father 
2 !5 
a 
3 7 
b 
Mother 
8 
c 
d 
9 !5 
Children 
2 3 7 
---a b 
2 
9 
c c 
8 8 
5 
a 
d 
3 7 
9 
b 
d 
F1c. I: The double lines represent a chromosome with 
two loci. a and b. The specificities determmed on each 
chromosome (haplotypes) are inherited as "packets" so 
that only four types of specillcities result from any 
mat ing. The numbers are HL-A designations. The fa -
ther's phenotype would be: HL-A2, HL-AS, HL-A:J, 
HL-A7 The father's genotype would be; HL-A2, HL-AS, 
H L-A:3, HL-A 7. The father's haplotypes would be 
HL-A2, HL-Aii. and HL-A3 and HL-Ai . 
quently on the same haplotype as HL-A8 but is 
rarely found with HL-Al2 orTefil. Bodmer [9] hab 
studied th is linkage disequilibrium with derivation 
of mathematical formulae expressing the level of 
significant deviations from random distribution. 
The importance or linkage disequilibrium liet; in 
the possible selection against certain haplotypes 
and the higher survival values or other haplotypes. 
Genetic studies of the gene fre4uencies calcu-
lated from family data have shown that the basic 
concept of the two separate series of specificities is 
correct [4. 10]. "Blank specificities .. are real speci-
ficities for which antisera are not yet available. As 
typing improves. fewer and fewer persons will be 
found who do not have four identifiable specifici-
ties. For example, persons who are homozygous for 
an antigen having HL-A2 on both chromosomes 
will appear to be blank on the first sublocus on the 
26 + Blank gene 
basis of phenotypes. Thus, not all persons with 
three or e\'en two antigens necessarily have blank 
undetected antigens. In the family shown in Figure 
2, segregation of melanoma incidence is unfortu-
nately with the HL-A chromosome which is blank 
or without known specificities. The mother and 
three sons with melanoma all have this chromo-
some. Other members inheriting the same chromo-
some should be observed carefully for possible 
melanoma development as compared to two others 
who inherited the W28, W5 haplotype. 
METHODOLOGY 
Testing for HL-A was lirst attempted by the 
leukoagglutination test m which leukocytes were 
agglutinated by antisera in the same way that red 
cell typing is performed. However, there were 
problems with reliability of this test, particularly 
since granulocytes tend to agglutinate nonspecifi-
cally. The lymphocyte cytotoxicity test was then 
introduced by Terasaki [4] and Walford et al [10] 
and developed into a practical test for large-scale 
testing by the introduction of microtechnics. The 
test basically consists of a reaction among lympho-
cytes, antibody, and complement. A positive reac-
tion results in the killing of lymphocytes. Stan-
dardized conditions include the use of I ~I of 
reagent and I ,000- 2,000 lymphocytes, which are 
incubated for 30 min before addition of 0.5 ~I of 
rabbit complement and further incubated for 1 hr, 
vital staining, and fixation. Incubation tempera-
ture has been set at 22°-22.5° C. Eosin dve with 
formaldehyde or trypan blue has been used com-
monly as the vital stain. Cell damage is deter-
mined by phase microsl·opy (index: swelling and 
cytoplasmic dye uptake by dead cells). 
Serum obtained from multiparous women or 
persons who have been accidentally or deliberately 
immunized with leukocytes from other humans is 
the reagent most commonly used. During preg-
nancy. mothers are immunized against antigens 
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MELANOMA FAMILY , 
9,7 9,7 9 ,7 9,7 9,7 1,8 1,8 9,7 1,8 
-::-=- W28, W5 -::-:;- -::-= W28,W5 
Mole Female 
• • WITH MELANOMA 
D 0 WITHOUT MELANOMA 
FIG. 2: Inheritance of blank specificities by melanoma 
patients in the family. 
present in the fetus which have been inherited 
from the father. Much of the immunization occurs 
during labor when bleeding across the placenta 
results m leakage of blood into the maternal 
ci rculation. rt is not known lo what extent immuni -
zation proceeds continuously durin?: pregnancy. 
Most antisera are multispecific because most 
women are immunized by two specificities on a 
haplotype, or . at times in two consecutive pregnan-
cies, from two specillcities of one haplotype of the 
father and two specificities of the other haplotype 
of the fa ther. It has been d iilicult to identify sera of 
a single specificity I hat produce definitively st rong 
reaction~. Identification and production of suffi . 
cient quantities ot high-qual ity typing reagents 
continues to be a difficult but important task in 
I he field of HL-A typm~. 
These serologic tests can reliably detect antigens 
present on lymphocytes and platelets with almost 
the same accuracy as the red cell antigens. Unlike 
the ABO antigens. there are no HL-A antigens that 
would regulruly lead to fatal results on transplan-
tation. In this sense, HL-A antigens are not over-
whelmingly st rong antigens, but s hould be consid-
ered intermediate in strength . HL-A typing is not 
known to be affected by irradiation. chemother-
apy, or other therapeutic modalities. However, 
interpreta tion of HL-A typing in infants requires 
caution since an infant with severe combined 
immunodeficiency disease has undergone an ap-
parent change of HL-A type which was a ttributed 
• to a placentally transferred blocking factor bearing 
HL-A l s pecificity Ill]. 
Most animal models that have been studied 
appear to possess a single major histocompatibility 
system. There is the H-2 locus in mice, AgB in rat!;. 
H -l in rabbits, Dl -A in dogs, and locus B in 
chickens. Antigens controlled by these loci usually 
.1 stand out as the strongest barrier to successful 
grafting among a number of genetically controlled 
~ transplantation antigens. 'l'h e others constitute the 
minor histocompatibility systems. 
MEANING OF ASSOCIATIONS WITH HL·A 
The facts about the H-~ locus in mice have been 
well established: detailed reviews of such studies 
with H-2 are provided by McDevitt and Bodmer 
[12) and Walford. Smith. and Waters (13). The 
advantage of the mouse is that it can be used as an 
experimental animal. can be infected with, for 
example, tumor-producing viruses, and is availa-
ble in genetically homogeneous, inbred strains. 
The many pitfalls involved in using HL-A typing 
as an epidemiologic tool in humans have also been 
discussed fully [6, 13]. Enough patients with the 
disease to constitute an adequate sample must be 
used. Also, one must be ~ ure that the t rait being 
compared is biologically meaningful and not 
merely an intervening variable. For example. hair 
color is related to various races and ethnic groups: 
one might find a relationship between HL-A types 
and hair color that is statistically significant but 
biologically meaningless because the relationship 
between HL-A types varies by racial and ethnic 
group. In a s imilar fashion, unknown genetic 
variables may be correlated with a particular 
disease state a nd also with HL-A so t hat the 
relationship between HL-A and disease is indirect. 
Another important pitfall that must be avoided 
in assessing the associations ofHL-A antigens and 
disease is that of overestimating the stat istical 
significance of an association due to the fact that it 
is an extreme one picked out of many possibilities. 
By definition of the term "statistically signifi-
cant,'' of 20 comparisons, by chance alone. one of 
them is expected to be significant at the 5 percent 
level. so that in a study of approximately 20 
different HL-A specificities, in cases versus their 
respective controls. it would not be surpris ing if 
one specificity were statistically s ignificantly dif-
ferent. According lo Croxton 1141. a rough gu ide for 
dealing with this problem is to multiply the normal 
significance level by the number of comparisons to 
get a corrected or "real significa nce" level. For 
example, if the p value for an HL-A s pecificity in 
the study of a disease state is 0.003 and there are 20 
different specificities being tested, the corrected p 
value would be 0.06 and the correct interpretation 
of this finding would be t hat it is a chance 
occurrence. 
The best way to ensure that an HL-A association 
is significant is by doing an independent follow-up 
survey to see whether the association has remained 
significant. If one does this, then the association 
one is looking for has been stipulated a priori and 
the statistical problem of picking out the extreme 
is circumvented (12. 14] . Probability values of 
differences in frequencies are determined by the 
pl-p2 test [14] and adjusted for the number of 
antigens tested in each segregated series. The 
Chi-square test of s ignificance may also be used. 
Linkage between a disease and HL-A cannot be 
ruled out by the absence or fai lure to detect 
relationships. Only a strong positive association 
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may suf(gest linkage disequilibrium. Several pub-
1 ished reports demonstrate the problem of too 
small a population with associatton~ which could 
not be reproduced on retesting e\·en by the same 
laboratory on another set of subjects 16. 8. 12. 13, 
15. 16] . 
The association of various disease states with 
particular HL-A antigens has been variously de-
scribed ru. due to one of the lollowin~t mechanisms: 
L A particular form of cell surface antigen 
might render a cell susceptible to viral infection or 
biochemical interaction with a stimulus by provid-
ing a receptor site for the attachment oft he ,·irus or 
chemical agent to the cell surface. 
2. Because of shared or cross-reacting antigentc 
determinants with particular viruses, the host may 
be unable to mount an immunologic defense: this 
would result in increased su~cepuhiltty of indind-
uals with certain HL-A antigens to particular viral 
infections (i.e., the theory of molecular mimicry 
and immunologic cross-tolerance) . 
3. The genes controlling the HL-A antigen 
might be fortuitously linked to, or be identical 
with, genes determining susceptibility to disease. 
In one example of this possibility HL-A genes 
might be linked to an .. immune response (lrl gene" 
which determines whether or not an indjvidual ts 
capable of making an immune response to certain 
antigens; such Ir genes have been extensively 
studied in mice and guinea pilr.' wherein the ability 
to make antibody responses to synthetic antigens 
appears to be linked to histocompatibility types 
[12]. Recently, genetic control of ragweed hay fever 
by immune response genes (lr genes) specific for 
antigen E (the major purilied protein antigen from 
ragweed pollen) has been shown to be linked to 
several HL-A types [17 ]. HL-A antigens may 
therefore be markers only for a susceptibility gene 
found on the same chromosome. 
Whether genetic control of unresponsiveness is 
due to linkage to the hi:;tocompatibility locus of a 
response gene or to tolerance from similartty with 
host antigens may be part tally answered by testing 
ofls pring as has been done m animal studies. If the 
inability to respond i~ due to tolerance to host 
antigens, the trait of susceptibility or unrespon-
siveness is dominant and a hereditary pattern of 
domtnance of this trait should be noted in the F1 
animals. However, tt has been found m animal 
studies that the response in F 1 to the polypeptide 
antiFtens and Gross virus leukemogenesis, as spe-
ctfic examples, indtcates that genetic control is 
other than dominant m pattern and is more than 
tolerance to one's own antigens [1 2]. 
HL-A ANTIGENS AND DISEASE 
Table 11 summanzes the patterns for various 
HL-A antigenic specilicities in various diseases. 
The highest degree of association between a disease 
state and a particular HL-A antigen exists for 
ankylosmg spondylitis and the W27 specificity. 
Two separate studies [18] have shown a frequency 
of W27 varying between 88-96 percent in patients 
with ankylosiog spondylitis compared with ap-
proximately 10 percent frequency of W27 in the 
matched controls (p < 0.00001) . Table III indi-
cates the skin diseases for which a disturbance in 
HL-A frequency has been noted. 
A topLc Diseases 
Classical studies in clinical allergy have shown a 
preponderance of atoptc allergic diseases in succes · 
sive generations of certain families [17]. Recent 
data have shown that HL-A associated lgE anti-
body responst\'eness is antigen specific and extends 
also to lgE antibody production [lij. Childhood 
asthma has been shown by Thorsby et al 119] to be 
TABLE II 
Dt~ease states and If /,·A anli,eens 
Disease 
Acute lymphoblastic leukemia 
Cystic fibrosis of pancreM 
Retinoblastoma 
Chronic glomerulonephritis 
Hodgkin's disease 
Cervical cancer 
Multiple sclerosis 
Choriocarcmoma 
Diabetes mellitus 
Celiac di~~ease 
Ankylosing spondylitis 
Childhood asthma 
Rheumatoid &Itbritis 
Chronic hepatitis 
Source: References 6. 12, 13, 18, 22, 23. and 25. 
Statisucally Signihcanl ( p < 0.051 
Increase 
HL-Al, HL-A2, HL-AS. Ti2 
Wa-Siah 
Wa-Siah 
HL-A2 
HL-A1 , HL A5(4c), W5, WIS 
HL-AL 
HL-A3, HL-A7, W18 
HL-AI. HL-A8 
HL-Al5 
HL-A1, HLA8 
W27 
HL-Al, HL-A8 
HL-Al3, WIO 
HL-Al, HI.-AS 
------------------
HL-A2, HL-A9 
HL-A2, W10 
HL-A7 
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l'AHLE lii 
Dermatolog1c disease.~ associated w1th particular HL-A 
antiJtPns 
"itato;.tu·nll' Sognolocunt 
'" 
(l();jl 
Dt-t·a-c ul Skon RPit·r~nu.• 
lnrreu'c Dt•· creo ... t~ 
Psona~ts HL-At:l, \\'li 1. la.:D 
System1c lupus HL-A , \\ li; 12.25,26 
erythematosus 
Pemph1gus vulgarts 
.Jews HL-AIO. \\'5 HL-A9 8 
:>Jon .. Jews \\'15 
__E_ Atoptc dermattti~ HL-A:l. HL-A9 Dermal it is herpeli· HL·AI. HL-A8 l form•~ 
related to specific HL-A types I and 8. Also. 
ragweed hay fever haR been linked to seven differ-
ent HL-A haplutypes: W18, x: HL-AlO. Da6: 
HL-A:J. 'i: HL-M. 5: HL-AI. 8: HL-A2. x: and 
HL-A1. Wl-1. Whether one or more of these hap-
lotypes will be frequently or always linked to an lr 
antigen E gene in other populat ions remains to be 
determmed. 
Ln a prelimina~ study 120] of 45 Caucastan 
patient~ with atoptc· dermutil i~ and 870 Caucasian 
contrnls <the patients with atopic dermatitis wen 
denoted by a history of infanti le eczema, llexural 
distribution of the eruption. and a classical mor-
phologic· appearan<·e). HL-A:~ and HL-A9 were 
increa!<ed in frequency versus the race- and sex-
matched controls. The:-.e antigenic spectli~:nw-; 
both occurred in 15 of -tfi patients (:3:3c·,) versus 19 
percent and :H percent. respecti,·ely. of the con-
trols !corrected p value. adJusted for the number of 
specifitities. 0.05). 
Pemphtgu . ., Vulgam 
HL AlO was f(>Und in 17 of 28 unrelated .Jewish 
patients wtth pemphiguli vulgaris !60.7' d as cum-
pared with 19 of 9-t control (,Jewish) pattents 
without pemphigus (20.1'r) (p < O.O!Xlll 18]. :'--:o 
significant associauons were noted for the other 
HL-A specificities m the non --Jewish Caucasians 
with pemphigu:> vulgaris (p > 0.05). The ditler· 
ence between the two groups of Caucasians points 
to the greater likelihood that a genetic linkage of a 
susceptibility gene is involved rather than a direct 
, cross-reaction of the etiologic agent wtth HL-AIO. 
Attempts to demons trate reaction between 
HL-A 10 coated leukocyte!> and pemphigus sera by 
indirect immunofluorescence have failed [8). Fail-
ure of pemphigus antisera to react with HL-A 10 
coated leukocytes need not rule out genetic cross-
reactivity, since H L-A 10 coaled eptdermal cells 
• were not tested . Such testing is currently in 
progresst. although Katz and co-workers [161 were 
:j: Terasaki PI: Personal communication 
unable to demonstrate hindmg of anttl'era to 
HL-A8 and WIO in the mdirect immunofluorescent 
test with skin from normal volunteers who had 
HL-A8 or WlO on their lymphocytes. These sera 
did not react with rhesus esophagus. Katz and 
co-workers [16j also noted that antt-HL-A sera did 
not react wilh pemph igus interepithelial antigen 
in an indirect immuno!luorescent test. As m our 
studies [81. they found that attempts to block 
reactivity of known pemphigus antiepitheltal ami-
bodies by prior mcubat ion on monkey esophagus 
with HL-A antisera were unsucces&ful. Hecause 
Katz and co-workers combined all forms ol pem-
phigu!:i in thetr -.;tudy and used a small number of 
patients. further studies of pemphigus. particu-
larly on .Jewish individuals who are predisposed to 
the "vulgaris'' form. are required. 
Drrmat1ti.' Herpeti{ormz., 
Reports have now confirmed that the HL-AI. 8 
haplotype is signilicantly increased 111 trequency m 
patients with celiac disease and dermatitib herpet i-
formis 121 ~:\]. Recent reports have established 
that approximately two-thirds or patients with 
dermatitis herpetiformis have gluten-sensiuve en-
teropathy [24 ]. Further. it has been reported that 
as many as 60 percent of patients with dermatitis 
herpetifor mis, u nonl'amilial-associuted disorder, 
have an increased incidence of HL-A8 as compared 
with the control groups. The immunologic linkage 
of HL-A8 to dermal ius her pet tlormis and jejunal 
mucosa factors requires further evaluation. 
Systemzc Lupu~o ET)thematosu~ 
Two studies have now shown a s tatistically 
s ignificant mcreased frequency of the Wl5 specific-
ity in systemic lupus erythemalosu:. as compared 
with appropriately matched control populations. 
McDevitt and Bodmer 112] have also noted a 
statistically s iKnificant increased frequency of 
HL-A8 but th1s was not conlirmed b~ Waters and 
co-workers 115 1. Terasakt§ has fa iled to reproduce 
any of these finding~ tn studies of over 100 patients 
to date. Grumet et al [26] who reported the 
increased frequencies of W 15 and HL-A8 had a 
racial mixture in theirl-eries and, since HL-A types 
varv by race. this conceivablv could account for the 
dirfere.nce in results. As n~ted earlier, however, 
failure to note a linkal{e disequilibrium doe:. not 
rule it out, especially tn light of the two posili\e 
studies. and further studies are needed by inde-
pendent investigator!< . 
Psorwsz~ 
Four separate studies in widely differing geo-
graphic regions. e.g., Stanford, California• . Mil -
waukee, Wisconsin [311. Los Angeles. California [7 ], and London. England " have now confirmed 
§Terasak1 PI · l npuhhs hed data 
' Unpublished data 
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the fact that Wl7 and HL-Al3 are statistically 
significantly increased in frequency in psoriasis 
compared with matched control groups [7, 27]. 
A recent study confirmed that there was no 
significant decrease in HL-A12 (p > 0.05) [15 ]. 
The most recent study by Terasaki§ of326 patients 
with psoriasis and 850 matched controls has shown 
that W17 is a useful genetic marker for detecting a 
subgroup of psoriatic patients characterized by a 
high rate of affected relatives and a mean age of 
onset of 18.2 years. Studies of 20 Caucasian three-
and four-generation families with psoriasis have 
clearly demonstrated that Wli is a definite genetic 
marker for the psoriatic condition in those patients 
over age 18 who could be typed. Four patients who 
carried W17 in the psoriatic family shown in Figure 
3 did not have obvious manifestations of psoriasis 
but they were ages 5, 6, 7, and 12. They are being 
followed to determine whether they will manifest 
psoriasis in the second decade of life. Those pa-
tients with HL-A13 had no hereditary history of 
psoriasis. Since psoriasis is a polygenic multifac-
torial disease with variable age at onset and 
variable familial occurrence, and is aggravated by 
a number of environmental factors including infec-
tion with beta hemolytic streptococci and other 
bacteria, the HL-A13 and W17 subgroups acquire 
special significance (Table TV). A type M protein 
from a Group A beta hemolytic streptococcus has 
been shown to cross-reacl with certain HL-A 
antigens (28] and, if this is applicable to psoriasis, 
the most likely HL-A antigen from previous studies 
(15] would be HL-A13. Table IV shows previously 
unpublished data from the laboratory of Dr. Paul 
Terasaki and the differing characteristics of psoria-
sis in those patients with HL-Al3 and W17. These 
groups clearly differ in age of onset. Wl7 patients 
appear to have more severe psoriasis than those 
with HL-A13 (p < 0.05). HL-Al3 patients appear 
PSORIASIS FAMILY , 
1, 
--------
Mol~ F~mol~ 
• • WITH PSORIASIS 
D 0 WITHOUT PSORIASIS 
Fie. 3: Inheritance of W17 through several genera-
tions. 
TABLE IV 
Characteristics of psoriatic patients with WI7 and 
HL-AJ3 
All other 
HL·A 
Characteris tic W17 HL-A13 group:; 
(weighted 
mean) 
Number of patients 108 83 135 
Mean age at onset (yr) 18.2 30.6 25.2 
Patients with antecedent 3'* 309( 7% 
streptococcal infections 
Patients with severe psoria· 31% 4% 5% 
sis 
Patients undergoing sponta- LO% 41% 18% 
neous remissions of disease 
Patients responding to Go- 10% 29% 30% 
eckerman regimen 
Patients responding to topi- L8% 6% 20% 
cal steroids alone 
Patients requiring no ther· 8% 16% 10% 
apy at present 
to have a more reversible type of psoriasis that 
responds to milder therapeutic agents to a greater 
degree than the W17 patients (p < 0.05). HL-Al3 
patients have a signilicantly greater (p < 0.05) 
tendency to give a history of antecedent strep-
tococcal infect ions 115]. 
The tentative nature of the results of these 
studies must he stressed since independent confir-
mation by investigators in two or more geo-
graphic locations is desirable to increase the reli-
ability and validity of these findings. As more dis-
eases are screened for HL-A it may be possible to 
determine more speciiically the nature of the asso-
ciation of HL-A with various skin and connective 
tissue diseases. 
The author wishes to thank Dr. Paull. Terasaki of the 
Department of Surgery. University of California, Los 
Angeles, for providing certain data for this paper. 
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